Condition
Rhinoscleroma
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (1)
P 4 (1)
Trial Status
Unknown2
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05431673Phase 1UnknownPrimary
Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma
NCT03326050Early Phase 1UnknownPrimary
Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma
NCT00747461Phase 4Terminated
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Showing all 3 trials